PubMed · 2003 · 15 citations · 6 references
Life SciencesCell BiologyOncologyApoptosisCell DivisionMolecular OncologyApoptosis In CancerColorectal CancerCell Growth RegulationCell Viability AssaysG1 Cell-cycle ArrestTelomerase Activity AssessmentTelomerase EnzymeTelomerase FunctionTelomerase InhibitorsTelomerase Regulation
BACKGROUND: Antisense telomerase RNA (anti-hTR) coupled with 2',5'-linked tetraadenylate (2-5A) shows an inhibitory effect on cell growth and induces apoptosis in certain kinds of cancer. This experiment examined the anti-hTR effect on gastric and colorectal cancer cells. MATERIALS AND METHODS: Gastric cancer cells CRL-5822, CRL-5971 and colorectal cancer cells HTB-38, CCL-247 were treated with repeated doses of anti-hTR. Cell growth and cell cycle parameters were analysed. Telomerase activity was measured by TRAP assay. Control oligonucleotides and normal fibroblast were used as control. RESULTS: After two doses of anti-hTR, the cell viability for CRL-5822, CRL-5971, HTB-38 and CCL-247 cells was reduced to 15%, 12%, 37% and 37%, respectively. The DNA histogram showed cells arrested at the G2/M-phase and the sub-G1 peak found indicated that apoptosis had occurred. CONCLUSION: Anti-hTR demonstrated inhibition of cell growth and cell cycle arrest on gastric and colorectal cancer cells through a telomerase regulation pathway. Its specificity towards cancerous tissues but not normal tissues suggested a potential for anti-cancer therapy.
6
The RNA Component of Human Telomerase
Junli Feng, Walter D. Funk, Sy-Shi Wang et al. · Science · 1995 · 2.2K citations
Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component
Yasuko Kondo, Shoji Koga, Tadashi Komata et al. · Oncogene · 2000 · 100 citations
Treatment of bladder cancer cells in vitro and in vivo with 2–5A antisense telomerase RNA
Seiji Koga, Yasuko Kondo, Tadashi Komata et al. · Gene Therapy · 2001 · 51 citations
Medicine, Cell Biology, Oncology +7